Company Overview of Carolus Therapeutics, Inc.
Carolus Therapeutics, Inc., a development-stage biopharmaceutical company, develops drugs for the treatment of acute and chronic inflammatory diseases in the United States. The company focuses on therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines, and prevent or reverse inflammation associated with an array of human diseases, including atherosclerosis, rheumatoid arthritis, multiple sclerosis, sepsis, organ transplantation, and cancer. Carolus Therapeutics, Inc. was incorporated in 2007 and is based in San Diego, California.
5626 Oberlin Drive
San Diego, CA 92121
Founded in 2007
Key Executives for Carolus Therapeutics, Inc.
Carolus Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Vaccinex, Inc.||United States|
|Sophion Bioscience Inc.||United States|
|T3D Therapeutics, Inc.||United States|
|Alcan Global Pharmaceutical Packaging, Inc.||United States|
|Innocutis Medical, LLC||United States|
Recent Private Companies Transactions
August 27, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Germany, PA | Life TechnologiesPosted: Nov 22
- Spring House, PA | Johnson & JohnsonPosted: Dec 05
- Houston, TX | Baylor College of MedicinePosted: Dec 07
- Spring House, PA | Leader of Pharmaceuticals, Medical Devices, and Consumer Goods CompanyPosted: Dec 06
Sponsored Financial Commentaries
To contact Carolus Therapeutics, Inc., please visit www.carolustherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.